/content/mofsl-website-adobe/fragments/open-demat-popup
style
hide-in-desktop

CervoMed Inc Share Price Today: Live Updates & Key Insights

CervoMed Inc share price today is $2.69, up -0.37%. The stock opened at $2.6999 against the previous close of $2.67, with an intraday high of $2.7889 and low of $2.66.

CervoMed Inc Share Price Chart

style
pb-0

CervoMed Inc

us-stock
To Invest in {{usstockname}}
/content/mofsl-website-adobe/demat-form-fields
style
sticky-block,pt-0
us-stock
style
pt-0

CervoMed Inc Share Price Performance

$2.69 -0.0037(-0.37%) CRVO at 27 Jul 2026 02:33 PM Biotechnology
Lowest Today 2.66
Highest Today 2.7889
Today’s Open 2.6999
Prev. Close 2.67
52 Week High 13.13
52 Week Low 2.13
Day’s Range: Low 2.66 High 2.7889
52-Week Range: Low 2.13 High 13.13
1 day return -
1 Week return -3.63
1 month return -24.06
3 month return -31.16
6 month return -52.93
1 year return -69.39
3 year return -44.79
5 year return -93.48
10 year return -

CervoMed Inc Institutional Holdings

Morgan Stanley - Brokerage Accounts 5.47

Vanguard Group Inc 2.62

Vanguard Capital Management, LLC 2.34

Vanguard Total Stock Mkt Idx Inv 1.85

Millennium Management LLC 1.54

Geode Capital Management, LLC 0.55

Vanguard Institutional Extnd Mkt Idx Tr 0.49

Renaissance Technologies Corp 0.47

BlackRock Inc 0.38

Byrne Asset Management LLC 0.38

XTX Topco Ltd 0.28

Citizens Financial Group Inc 0.28

Fidelity Extended Market Index 0.28

Vanguard Fiduciary Trust Co 0.27

Northern Trust Corp 0.22

Cetera Investment Advisers 0.20

Savvy Advisors Inc 0.19

State Street Corp 0.15

iShares Micro-Cap ETF 0.14

Jane Street Group LLC 0.13

Blackrock Extended Mkt Fund CF 0.09

Extended Equity Market Fund B 0.09

Extended Equity Market Fund E 0.09

Northern Trust Extended Eq Market Idx 0.09

HighTower Advisors, LLC 0.08

FMR Inc 0.08

Thompson Davis & Co Inc 0.07

BlackRock Extended Equity Market Fund K 0.07

Spartan Extended Market Index Pool F 0.07

Fidelity Total Market Index 0.07

Fidelity Series Total Market Index 0.07

Fidelity Nasdaq Composite Index 0.05

NT Ext Equity Mkt Index Fund - Lending 0.05

NT Ext Equity Mkt Index Fund - NL 0.04

Vanguard Instl Ttl Stck Mkt Index Trust 0.04

UBS Group AG 0.04

Spartan Total Market Index Pool G 0.04

NT Ext Eq Mkt Idx Fd DC Lending Tier 5 0.03

NT Ext Equity Mkt Idx Fd - DC - NL - T2 0.03

Northern Small Cap Core I 0.03

CervoMed Inc Market Status

Strong Buy: 5

Buy: 1

Hold: 1

Sell: 0

Strong Sell: 0

CervoMed Inc Fundamentals

Market Cap 24.72 M

PB Ratio 2.4159

PE Ratio 0.0

Enterprise Value 12.72 M

Total Assets 23.40 M

Volume 118076

CervoMed Inc Company Financials

Annual Revenue FY23:0 0.0M, FY22:0 0.0M, FY21:0 0.0M, FY20:0 0.0M, FY19:0 0.0M

Annual Profit FY23:null 0.0M, FY22:null 0.0M, FY21:null 0.0M, FY20:null 0.0M, FY19:null 0.0M

Annual Net worth FY23:-11125256 -11.1M, FY22:-15591428 -15.6M, FY21:-24095727 -24.1M, FY20:-14185306 -14.2M, FY19:-11799379 -11.8M

Quarterly Revenue Q1/2026:0 0.0M, Q3/2025:322569 0.3M, Q2/2025:1757724 1.8M, Q1/2025:1917000 1.9M, Q3/2024:0 0.0M

Quarterly Profit Q1/2026:null 0.0M, Q3/2025:322569 0.3M, Q2/2025:-3350901 -3.4M, Q1/2025:-2920307 -2.9M, Q3/2024:null 0.0M

Quarterly Net worth Q1/2026:-7964158 -8.0M, Q3/2025:-7726639 -7.7M, Q2/2025:-6258404 -6.3M, Q1/2025:-4894034 -4.9M, Q3/2024:-4753541 -4.8M

About CervoMed Inc & investment objective

Company Information CervoMed Inc., a clinical-stage biotechnology company, engages in the development and commercialization of treatments for age-related neurologic disorders. The company is developing neflamapimod, an orally administered small molecule drug that crosses the blood"brain barrier and inhibits the enzyme p38a. Neflamapimod has the potential to reverse synaptic dysfunction, improve neuron health, and slow or prevent disease progression. Neflamapimod is currently in clinical development for the treatment of dementia with Lewy bodies, non-fluent variant primary progressive aphasia, amyotrophic lateral sclerosis, and amyotrophic lateral sclerosis. CervoMed Inc. was founded in 2010 and is headquartered in Boston, Massachusetts.

Organisation Biotechnology

Employees 15

Industry Biotechnology

CEO Dr. John J. Alam M.D.

Trading and brokerage services provided by

Technology Services provided by Motilal Oswal Financial Services:

Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*

Take your next step

Talk to our investment advisor for stock recommendations
Left
Get expert assistance for portfolio management
Right
style
align-center,button-arrow

CervoMed Inc FAQs

What is the share price of CervoMed Inc today?

The current share price of CervoMed Inc is $2.69.

Can I buy CervoMed Inc shares in India?

Yes, Indian investors can buy CervoMed Inc shares by opening an international trading and demat account with Motilal Oswal.

How to buy CervoMed Inc shares in India?

You can easily invest in CervoMed Inc shares from India by:

Can I buy fractional shares of CervoMed Inc?

Yes, many platforms allow you to buy fractional shares starting from as low as $1.

What is the market capitalization value of CervoMed Inc?

CervoMed Inc has a market cap of $24.72 M.

In which sector does CervoMed Inc belong?

CervoMed Inc operates in the Biotechnology sector.

What documents are required to invest in CervoMed Inc stocks?

To invest, you typically need:

What is the PE and PB ratio of CervoMed Inc?

The PE ratio of CervoMed Inc is N/A and the PB ratio is 2.42.